Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorderQiusui Mai, Ling Zhang, Bailin He et al.|Experimental Hematology and Oncology|2024Cited by 11
Interleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathwaysBailin He, Na Xu, Chengyao Li et al.|Experimental Hematology and Oncology|2025Cited by 6
Correction: Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorderQiusui Mai, Ling Zhang, Chengyao Li et al.|Experimental Hematology and Oncology|2024Cited by 0